GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Healius Ltd (ASX:HLS) » Definitions » EV-to-FCF

Healius (ASX:HLS) EV-to-FCF

: 11.10 (As of Today)
View and export this data going back to 1998. Start your Free Trial

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Healius's Enterprise Value is A$2,408 Mil. Healius's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was A$217 Mil. Therefore, Healius's EV-to-FCF for today is 11.10.

The historical rank and industry rank for Healius's EV-to-FCF or its related term are showing as below:

ASX:HLS' s EV-to-FCF Range Over the Past 10 Years
Min: -673.02   Med: 18.9   Max: 96.48
Current: 11.12

During the past 13 years, the highest EV-to-FCF of Healius was 96.48. The lowest was -673.02. And the median was 18.90.

ASX:HLS's EV-to-FCF is ranked better than
71.43% of 105 companies
in the Medical Diagnostics & Research industry
Industry Median: 24.36 vs ASX:HLS: 11.12

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-16), Healius's stock price is A$1.21. Healius's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-1.621. Therefore, Healius's PE Ratio for today is At Loss.


Healius EV-to-FCF Historical Data

The historical data trend for Healius's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healius Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-FCF
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 92.67 13.16 8.91 7.68 13.46

Healius Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 7.68 - 13.46 -

Competitive Comparison

For the Diagnostics & Research subindustry, Healius's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healius EV-to-FCF Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Healius's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Healius's EV-to-FCF falls into.



Healius EV-to-FCF Calculation

Healius's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2408.281/216.9
=11.10

Healius's current Enterprise Value is A$2,408 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Healius's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was A$217 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Healius  (ASX:HLS) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Healius's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.21/-1.621
=At Loss

Healius's share price for today is A$1.21.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Healius's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-1.621.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Healius EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Healius's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Healius (ASX:HLS) Business Description

Traded in Other Exchanges
N/A
Address
161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000
Healius is Australia's second-largest pathology provider and third-largest diagnostic imaging provider. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging.

Healius (ASX:HLS) Headlines

No Headlines